Liver/Biliary Disorders News

Protection provided by the mRNA COVID vaccinations is slower to build to efficacy and lower overall in patients with cirrhosis as compared to unvaccinated controls, according to a presentation at The Liver Meeting Digital Experience.

Data used well via artificial intelligence and transparent algorithms offers health care a glimpse into democratization and equitable, efficient and efficacious care, according to an expert speaking at The Liver Meeting Digital Experience.

Among patients with cirrhosis, younger age, active tobacco use, fewer medical comorbidities and residence in the southern United States correlated with decreased rates of COVID-19 vaccination.

There was an 81% increase in alcohol-associated hepatitis admissions within the first year of the COVID-19 pandemic and resulted in a significant increase in liver transplantation, according to a presentation.

Post-liver transplant recipients who were fully vaccinated against COVID-19 saw a decrease in COVID-19 infection or death, according to a presentation at The Liver Meeting Digital Experience.

More than 40% of hepatology providers said burnout during the COVID-19 negatively impacted their well-being, including work fulfillment and satisfaction, according to a presentation at The Liver Meeting Digital Experience.

Early in the COVID-19 era, liver transplantation decreased overall with a lower graft survival at 90-day post-transplantation and higher organ rejection rate, according to a presentation at The Liver Meeting Digital Experience.

Terns Pharmaceuticals announced positive top-line results from a phase 1 clinical trial of TERN-501, a thyroid hormone receptor beta agonist for the treatment of nonalcoholic steatohepatitis, according to a press release.

Adults with nonalcoholic steatohepatitis and obesity have a much lower risk for a major adverse liver outcome or major adverse cardiovascular event if they undergo bariatric surgery vs. nonsurgical treatment, according to study data.

The AGA published clinical practice guidelines in Gastroenterology for the management of coagulation disorders among patients with cirrhosis.